Clinical summary
Drug
Indications
Cautions
Side effects
Dosage
Notes
Inhalational agents
Myocardial protection during general anesthesia for cardiac and noncardiac surgeries
Myocardial protection is dose and duration of inhalational anesthetic agent dependent
Common side effects of inhalational agents such as hypotension, myocardial depression, arrhythmias, and effects on other solid organs
Unclear at the moment
Myocardial protection, decrease in infarct size, and reduction in mortality during cardiac surgery have been well documented. However, the benefit during noncardiac surgery has not yet been convincingly shown
References
1.
2.
3.
Fleisher LA, Beckman JA, Brown KA et al (2007) ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary. A report of the American college of cardiology/American heart association task force on practice guidelines (Writing committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). J Am Coll Cardiol 50:1707–1732PubMedCrossRef
4.
5.
Boutros A, Wang J, Capuano C (1997) Isoflurane and halothane increase adenosine triphosphate preservation, but do not provide additive recovery of function after ischemia, in preconditioned rat hearts. Anesthesiology 86:109–117PubMedCrossRef